Provided by Tiger Trade Technology Pte. Ltd.

AVECHO BIOTECHNOLOGY LTD

0.021
+0.00210.53%
Volume:6.55M
Turnover:127.39K
Market Cap:81.14M
PE:-15.00
High:0.021
Open:0.020
Low:0.019
Close:0.019
52wk High:0.027
52wk Low:0.005
Shares:3.86B
Float Shares:1.90B
Volume Ratio:3.04
T/O Rate:0.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.001
EPS(LYR):-0.001
ROE:-182.91%
ROA:-40.85%
PB:52.02
PE(LYR):-15.00

Loading ...

Company Profile

Company Name:
AVECHO BIOTECHNOLOGY LTD
Exchange:
ASX
Establishment Date:
1992
Employees:
15
Office Location:
Hallmarc Business Park,Unit A8,2A Westall Road,Clayton,Victoria,Australia
Zip Code:
3168
Fax:
61 3 9002 5000
Introduction:
Avecho Biotechnology Limited, a biotechnology company, develops, produces, sells, and licenses products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries. The company operates through Production, Human Health, and Animal Health and Nutrition segments. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company serves customers in Australia, Switzerland, the United States, India, Japan, China, Singapore, and internationally. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited is based in Melbourne, Australia.